Who Just Raised

Gossamer Bio, Inc.

San Diego, CA · Biotechnology

Gossamer Bio, Inc. is a biotechnology company based in San Diego, California. In a Form D filed with the SEC on September 4, 2026, it reported raising $25,000,000 from 38 investors as part of an offering of up to $150,000,000. The first sale in the offering took place on August 20, 2026.

Science Seralutinib Seralutinib is an inhaled PDGFRα/β, CSF1R, and c‑KIT inhibitor designed to be delivered via dry powder inhaler for the potential treatment of pulmonary arterial hypertension (PAH)…

Website
gossamerbio.com
Amount raised
$25,000,000
Offering size
$150,000,000
Investors so far
38
First sale
August 20, 2026
Securities offered
Options or warrants, Securities issuable on exercise or conversion
Exemption claimed
Rule 506(b)
Industry
Biotechnology
Headquarters
San Diego, California
Incorporated
Delaware
Entity type
Corporation

Filings

FiledFormRaisedOffering sizeInvestorsSource
D (new notice) $25,000,000 $150,000,000 38 SEC filing

Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.

Other health care raises in California

Company Location Sector Raised Target Filed
iPill Inc. Rowland Heights, CA Health Care $1.3M $1.5M
White Eagle Sonic Technologies, Inc. Santa Clara, CA Health Care $385K $1M
Digestive Disease Center, L.P. Laguna Hills, CA Health Care — $320K
Lionheart Health, Inc. Huntington Beach, CA Health Care $388K $3M
Anvion Bio, Inc. San Diego, CA Health Care $100K $1M
Rakuten Medical, Inc. San Diego, CA Health Care $9M $9M